Results of the national registry of patients diagnosed with inflammatory bowel disease candidates for bariatric surgery (ReNacEIBar)

Abstract

Background: Our aim is to carry out a national registry of patients with inflammatory bowel disease (IBD) who underwent bariatric surgery, as well as evaluate the results and management of this type of patients in the usual clinical practice.

Methods: National multicentric observational retrospective study, including patients, previously diagnosed with IBD who underwent bariatric surgery from January 2000 to December 2022.

Results: Forty-one patients have been included: 43,9% previously diagnosed with ulcerative colitis, 57,3% Crohn's disease, and an indeterminate colitis (2,4%). The preoperative BMI was 45.8 ± 6,1 kg/m². Among the bariatric surgeries, 31 (75,6%) sleeve gastrectomy, 1 (2,4%) gastric bypass and 9 (22%) one anastomosis gastric have been carried out. During the postoperative period, 9.8% complications have been recorded. BMI was 29,5 ± 4,7 kg/m² and percent total weight lost was 33,9 ± 9,1% at 12 months.

Conclusions: Bariatric surgery in patients with inflammatory bowel disease can be considered safe and effective.

Keywords: BAGUA; Bariatric surgery, gastric bypass; Cirugía bariátrica, bypass gástrico; Colitis ulcerosa, enfermedad Crohn; Enfermedad inflamatoria intestinal; Gastrectomía vertical laparoscópica; Inflammatory bowel disease; Laparoscopic sleeve gastrectomy; RENACEIBAR; Ulcerative colitis, Crohn disease.